ANAHEIM, Calif., Oct. 04, 2017 -- GreenGro Technologies, Inc. (OTC:GRNH), a world-class provider of eco-friendly green technologies, today announced the debut of its state-of-the-art and consumer-oriented food cloning and breeding website, which is designed to support the launch of Genobreeding, the Company’s wholly-owned subsidiary which will primarily focus on the cloning and breeding of both food and the highest in demand cannabis strains for resale into the market. The site can be found at www.genobreeding.com.
“The launch of this site will provide our consumers with access to Genobreeding’s state-of-the-art breeding techniques that are expected to help breeders and growers develop some of the highest quality cannabis plants both in a greenhouse as well as in the fields,” said James Haas, Chief Executive Officer of GreenGro Technologies, Inc. “Some of the site’s services will enable the genotyping and fingerprinting of plant species, provide tissue culture and cloning boxes to develop disease and insect free plant clones and consulting services to implement state-of-the-art breeding techniques to develop high yielding, high quality plant and crop strains for commercial use. And finally, the site will add yet another new and growing revenue channel to GreenGro’s total mix of revenues derived from the cannabis industry, positioning us as on the leading and most diversified cannabis entities in the industry today,” concluded Mr. Haas.
About GreenGro Technologies, Inc.
GreenGro Technologies, Inc. (OTC:GRNH) is a national leader in both indoor and outdoor aquaponic and hydroponic systems and grow rooms, with specific domain expertise in agricultural science systems serving both the consumer and commercial farming markets. The company’s customers include restaurants, community gardens, and small- and large-scale commercial clients. For more up to date info like our Facebook page at https://www.facebook.com/GreengroTechnologiesInc?ref=hl
For additional investor please contact Bill Miller at [email protected] or at 844-565-5665.
About Genobreeding Inc.
GreenGro Technologies, Inc., (OTC:GRNH) launched Genobreeding in early 2017 to direct a corporate initiative intended to introduce cutting-edge plant varieties to the cannabis market through the application of modern plant breeding technologies designed to meet the increased consumer demand and improve overall production profitability.
Disclaimer: The Company relies upon the Safe Harbor Laws of 1933, 1934 and 1995 for all public news releases. Statements, which are not historical facts, are forward-looking statements. The company, through its management, makes forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are necessarily estimates reflecting the company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors. Factors which could cause actual results to differ materially from those estimated by the company include, but are not limited to, government regulation; managing and maintaining growth; the effect of adverse publicity; litigation; competition; and other factors which may be identified from time to time in the company’s public announcements.
Investor/Media Contact:
Bill Miller
Investor Relations Partners
[email protected]
www.irpartnersinc.com
Phone: 844-565-5665


SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Instagram Outage Disrupts Thousands of U.S. Users
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 



